Houlihan Lokey

Houlihan Lokey is a global investment bank with extensive healthcare sector expertise, providing mergers and acquisitions advisory, capital solutions, financial restructuring, and valuation services. The firm ranks #1 for all global M&A transactions in 2025 with 458 deals and holds the #1 position for global healthcare M&A transactions with 45 deals.

The Healthcare Group operates across 17 specialized sectors including behavioral health, medical technology, pharmaceuticals, physician services, post-acute care, healthcare technology, and payor services. The firm serves public and private strategic buyers, financial sponsors, and operates through offices across the Americas, Europe, Middle East, and Asia-Pacific regions.

The firm has completed notable healthcare transactions including the sale of DirectMed Imaging to Frazier Healthcare Partners, TriMed's majority sale to Henry Schein, and Tyber Medical's merger with InTech and Resolve Surgical Technologies. Houlihan Lokey also ranks as the most active advisor to private equity globally with 232 deals in 2024.

Consider Houlihan Lokey when planning a healthcare business sale, acquisition, recapitalization, or restructuring that requires deep sector knowledge and global transaction expertise. The firm excels in situations requiring specialized healthcare subsector understanding, from behavioral health roll-ups to medical device manufacturer acquisitions.

Clients should expect a transaction-focused engagement with extensive industry benchmarking, buyer/seller identification, and deal structuring capabilities backed by quantifiable market leadership in healthcare M&A volume.

Houlihan Lokey maintains dedicated healthcare sector coverage through specialized teams spanning behavioral health, medical technology, pharmaceuticals, healthcare IT, physician services, post-acute care, oral health, and payor services. The firm's healthcare practice completed 45 global healthcare M&A transactions in 2025, demonstrating consistent activity across the sector.

The healthcare group serves clients across the entire care continuum from medical device manufacturers and pharmaceutical services to behavioral health providers, dental service organizations, and senior housing operators. Recent transactions include sales of medical imaging companies, dental product manufacturers, and physician practice management platforms to both strategic buyers and private equity sponsors.

The ideal client is a healthcare company valued at $50 million or above, private equity firms with healthcare portfolio companies, or health systems evaluating strategic transactions. Companies in high-activity subsectors like behavioral health, physician services, medical technology, and healthcare IT represent particularly strong fits given the firm's demonstrated transaction volume.